JULIA WILLIAMS: Open Payments
NPI 1588365274 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| Dexcom, Inc. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $46 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| ABIOMED | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| Abbott Laboratories | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: Dexcom G6 Transmitter, Veozah, Ozempic, SHINGRIX, PREVNAR 20, FREESTYLE LIBRE 3, Rybelsus, XIFAXAN.
Industry payments across GA — which companies pay providers there.
